{"id":50,"date":"2023-03-30T13:44:23","date_gmt":"2023-03-30T12:44:23","guid":{"rendered":"http:\/\/molecularhealth.com\/eu\/?page_id=50"},"modified":"2025-09-04T15:14:00","modified_gmt":"2025-09-04T14:14:00","slug":"about-us","status":"publish","type":"page","link":"https:\/\/molecularhealth.com\/eu\/about\/about-us\/","title":{"rendered":"About us"},"content":{"rendered":"
\r\n
\r\n
\r\n
\r\n \r\n
\r\n

About us
Evidence-based decisions.
Data-driven, action-ready. \r\n <\/h1>\r\n <\/div>\r\n \r\n
<\/i> See our story<\/span><\/a><\/div> <\/span>\r\n <\/div>\r\n\r\n \r\n
\r\n

Molecular Health is a leader in the hybridization of medicine<\/strong> determined to empower healthcare professionals and therapy developers with the latest advances in artificial intelligence and data-driven technology to deliver better patient outcomes. Our mission is to build software solutions<\/strong> that tap into a unique collaboration between human expertise and cutting-edge data curation and deep analytics<\/strong> that connects and scales out the world\u2019s biomedical knowledge, unfolding insights to transform that knowledge into action<\/strong>.<\/p><\/span>\r\n <\/div>\r\n \r\n <\/div>\r\n<\/div>\r\n\r\n

\r\n

Molecular Health is a leader in the hybridization of medicine<\/strong> determined to empower healthcare professionals and therapy developers with the latest advances in artificial intelligence and data-driven technology to deliver better patient outcomes. Our mission is to build software solutions<\/strong> that tap into a unique collaboration between human expertise and cutting-edge data curation and deep analytics<\/strong> that connects and scales out the world\u2019s biomedical knowledge, unfolding insights to transform that knowledge into action<\/strong>.<\/p><\/span>\r\n <\/div>\r\n<\/div>\n\n\n

<\/div>\n\n\n\n

We make knowledge usable, for healthcare professionals, clinical laboratories, and researchers<\/h2>\n\n\n\n
\n
\n

To that end, we:<\/strong><\/h4>\n\n\n\n
\n
\n
Focus on patients<\/strong><\/h5>\n\n\n\n

Our work aims to improve the quality and speed of treatment and care options.<\/p>\n<\/div>\n\n\n\n

\n
Deliver usable results<\/strong><\/h5>\n\n\n\n

A transparent, intuitive, and informative user experience is at the core of our solutions.<\/p>\n<\/div>\n\n\n\n

\n
Promote innovation<\/strong><\/h5>\n\n\n\n

Our solutions evolve to meet current healthcare needs and recommendations.<\/p>\n<\/div>\n\n\n\n

\n
Build on diversity<\/strong><\/h5>\n\n\n\n

Our teams tackle challenges with diverse ideas, strengths, and backgrounds.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

Our people:
our greatest asset<\/h2>\n<\/div>\n\n\n\n
\n

Partnering with Molecular Health means more than using cutting-edge solutions like MH Guide for clinical decision support and Dataome Technology for AI-guided drug development. Our talented team of experts is like an extension of your efforts to grow and use knowledge.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Our highly skilled subject matter experts ensure that our solutions always provide clean, relevant, high-quality data and top analytical performance to guide personalized therapy decisions and overcome some of the biggest hurdles in drug development. Our analytics experts engineer the analysis functions of MH Guide and the dedicated data-driven analyses for AI Pharma Solutions. Their analytical strategies are documented and traceable, so customers can rely on our solutions and services to tackle challenges.<\/p>\n\n\n\n

Read about our work:<\/p>\n\n\n

\r\n <\/i> MH Guide<\/span><\/a> <\/i> Dataome Technology<\/span><\/a> <\/i> AI Pharma Solutions<\/span><\/a> <\/section>\r\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Our database experts work behind the scenes to vet, organize, structure, and connect the massive datasets that are wrangled, standardized, and integrated from numerous sources into Dataome. Concurrently, our professional biomedical data curators keep a finger on the state of biomedical knowledge \u2013 from real-world data, molecular findings, and genomic insights to recommendations from authorities and regulatory drug approvals. Their work ensures that our solutions remain highly reliable, current, relevant, and useful to those who use them. In fact, our curators highlight high-impact publications, which we share with customers in our newsletter.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Finally, our Customer Success Team includes application specialists who ensure that our partners are able to use MH Guide to its fullest potential, providing guidance and support as needed. So, when you choose Molecular Health, you’re getting powerful tools and a team of experts who work to grant you cutting-edge, evidence-based insights that underscore meaningful decisions in healthcare and drug development.<\/p>\n\n\n\n

Do you want to join our young and engaged team of experts?<\/p>\n\n\n

\r\n <\/i> See our job postings<\/span><\/a> <\/section>\r\n<\/div><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n

Our management team<\/h2>\n<\/div>\n<\/div>\n\n\n\n
\n
\r\n
\r\n \"\"

Friedrich von Bohlen und Halbach, PhD
Chief Executive Officer<\/h2>\r\n
\r\n

Friedrich von Bohlen und Halbach, PhD
Chief Executive Officer<\/h2>

Chief Executive Officer<\/strong><\/p>

Friedrich von Bohlen und Halbach is a co-founder of Molecular Health. He has over 25 years of entrepreneurial experience in the industry and serves as chairman or board member of several national and international biotech companies and organizations. He holds a diploma in biochemistry from the University Zurich and a PhD in neurobiology from the Swiss Federal Institute of Technology, Zurich.<\/p> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

\r\n
\r\n \"\"

Stephan Brock, PhD
Chief Technology Officer<\/h2>\r\n
\r\n

Stephan Brock, PhD
Chief Technology Officer<\/h2>

Chief Technology Officer<\/strong><\/p>

Stephan Brock is co-founder of Molecular Health. He has extensive experience in bioinformatics, data integration analytics, artificial intelligence, text-data mining, and content management for the pharmaceutical industry. He has led large-scale projects developing bioinformatics solutions supporting the pharma R&D value chain and IT infrastructure for integrative clinical trial data management at cancer centers. He holds a PhD in biochemistry from the University of Bayreuth.<\/p> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

\r\n
\r\n \"\"

Burkard Piper
Member of the Executive Team<\/h2>\r\n
\r\n

Burkard Piper
Member of the Executive Team<\/h2>

Member of the Executive Team<\/strong><\/p> <\/div>\r\n <\/div><\/div><\/div>\n<\/div>\n\n\n\n

\n
\r\n
\r\n \"\"

Matthias Kopf, PhD
SVP, Head of Business Unit Molecular Analysis Solutions<\/h2>\r\n
\r\n

Matthias Kopf, PhD
SVP, Head of Business Unit Molecular Analysis Solutions<\/h2>

SVP, Head of Business Unit Molecular Analysis Solutions<\/strong><\/p>

Matthias Kopf took over the leadership of the Business Unit Molecular Analysis Solutions in 2023 after serving as Head of Product Management for five years. In his role, he oversees product management, customer success, medical affairs, marketing, and sales activities. He has a background in molecular biology and bioinformatics, having obtained his PhD in bioinformatics from the University of Freiburg (Germany), in 2015.<\/p> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

\r\n
\r\n \"\"

Josef Hermanns, PhD
SVP, Head of Project Management<\/h2>\r\n
\r\n

Josef Hermanns, PhD
SVP, Head of Project Management<\/h2>

SVP, Head of Project Management<\/strong><\/p>

Josef Hermanns has over two decades of experience in strategic growth planning for IT, project controlling, and bioinformatics development. At Molecular Health, he coordinates central and AI Pharma Service projects, manages resources and licenses in R&D, and oversees data curation and content management for Dataome. He has a PhD from the Ruhr University Bochum (Germany).<\/p> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

\r\n
\r\n \"\"

Niels Bojunga, PhD
SVP of Quality Management<\/h2>\r\n
\r\n

Niels Bojunga, PhD
SVP of Quality Management<\/h2>

SVP of Quality Management<\/strong><\/p>

Niels Bojunga is a microbiologist by training with over 20 years of professional experience in the area of software quality. As Head of Quality Management at Molecular Health, he oversees the company\u2019s quality management system and quality assurance and guides regulatory compliance and certifications. He is the Quality Management Representative and Person Responsible for Regulatory Compliance (PRRC) of Molecular Health.<\/p> <\/div>\r\n <\/div><\/div><\/div>\n<\/div>\n\n\n\n

\n
\r\n
\r\n \"\"

Thorsten Vogt
Head of Human Resources<\/h2>\r\n
\r\n

Thorsten Vogt
Head of Human Resources<\/h2>

Head of Human Resources<\/strong><\/p>

Thorsten Vogt has led Human Resources at Molecular Health since 2015. During that time, he guided the strategic expansion of all company sites and fostered the integration of employees from over 30 different countries. He oversees all personnel affairs, leveraging expertise from over two decades of managerial experience at international software and industrial corporations.<\/p> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n

Your contacts<\/h2>\n<\/div>\n<\/div>\n\n\n\n
\n
\r\n
\r\n \"\" <\/a>

Marc-Alexander Rauschendorf, PhD
Head of Medical Affairs & Marketing<\/h2>\r\n
\r\n

Marc-Alexander Rauschendorf, PhD
Head of Medical Affairs & Marketing<\/h2>

Head of Medical Affairs & Marketing <\/strong><\/p>

Reach out to Marc with questions about clinical trials, medical collaborations, tumor board support and KOL management. He also oversees attendance at conferences, outreach, PR, and publications.<\/p> <\/i> Reach out to Marc<\/span><\/a> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

\r\n
\r\n \"\" <\/a>

Lenka Kyjacova, PhD
VP, Customer and Partner Success<\/h2>\r\n
\r\n

Lenka Kyjacova, PhD
VP, Customer and Partner Success<\/h2>

VP, Customer and Partner Success<\/strong><\/p>

Lenka and her team help customers and partners implement MH\u2019s Molecular Analysis Solutions. She supervises global product support, partner training, and develops strategies to enhance adoption, satisfaction, and retention.\u00a0<\/p> <\/i> Reach out to Lenka<\/span><\/a> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
\n
\r\n
\r\n \"\" <\/a>

Melanie Baumh\u00f6gger
Head of Finance\u00a0<\/h2>\r\n
\r\n

Melanie Baumh\u00f6gger
Head of Finance\u00a0<\/h2>

Head of Finance<\/strong>\u00a0<\/p>

Melanie handles any finance-related questions, from invoicing and purchase orders to accounts payable, fiscal statements, value added tax, and accounting.<\/p> <\/i> Reach out to Melanie<\/span><\/a> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

\r\n
\r\n \"\" <\/a>

Biljana Blagojevic, PhD
Scientific Lead & Business Development Manager AI Pharma Solutions<\/h2>\r\n
\r\n

Biljana Blagojevic, PhD
Scientific Lead & Business Development Manager AI Pharma Solutions<\/h2>

Scientific Lead & Business Development Manager AI Pharma Solutions<\/strong><\/p>

Whether you\u2019re seeking a first contact, have specific questions about a possible collaboration, or want quick support within your ongoing AI Pharma Service project, get in touch with Biljana.<\/p> <\/i> Reach out to Biljana<\/span><\/a> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

Our Board of Directors<\/h2>\n\n\n\n
\n
\r\n
\r\n \"\"

Mathias Hothum, PhD
Member of the Board of Directors<\/h2>\r\n
\r\n

Mathias Hothum, PhD
Member of the Board of Directors<\/h2>

is the managing director of dievini Hopp Biotech holding GmbH & Co. KG. He is currently also the founder and owner of HMM Consulting and the managing director of MSL Investments, DH Holding Verwaltungs, and MH-LT-Investments GmbH. He serves as Chairman of the Board of Joimax GmbH and Geuder AG, and as board member of Apogenix AG, CureVac NV, Heidelberg Pharma AG, and Novaliq GmbH. He studied business administration at the University of Mannheim and holds a PhD from the University of Magdeburg, Germany.<\/p> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

\r\n
\r\n \"\"

Alexander O. Schuth, PhD
Member of the Board of Directors<\/h2>\r\n
\r\n

Alexander O. Schuth, PhD
Member of the Board of Directors<\/h2>

is co-founder and Chief Operating and Financial Officer of Denali Therapeutics, a biotechnology company focused on developing therapies for neurodegenerative diseases. He has extensive experience in corporate development, portfolio management, and finance. Before joining Denali, he worked at Genentech and the investment banking group at Merrill Lynch. He holds an M.D. from Humboldt University in Berlin and an M.B.A. from the Wharton School of the University of Pennsylvania.<\/p> <\/div>\r\n <\/div><\/div><\/div>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n

Invest in precision medicine<\/h2>\n\n\n\n

Molecular Health is privately funded by dievini Hopp Biotech holding GmbH & Co. KG<\/a>, which invests in innovative precision medicine companies with a focus on oncology, neurology, infectious diseases, cell therapy, and improved drug formulation. They support companies in their global development and marketing, with a geographic focus on Germany and Europe.<\/p>\n\n\n\n

Do you have additional questions about our solutions and services? We want to hear from you!<\/p>\n\n\n

\r\n <\/i> Contact us today <\/span><\/a> <\/section>\r\n<\/div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

We make knowledge usable, for healthcare professionals, clinical laboratories, and researchers To that end, we: Focus on patients Our work aims to improve the quality and speed of treatment and care options. Deliver usable results A transparent, intuitive, and informative user experience is at the core of our solutions. Promote innovation Our solutions evolve to […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":48,"menu_order":200,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"content-type":"","inline_featured_image":false,"footnotes":""},"class_list":["post-50","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/50","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/comments?post=50"}],"version-history":[{"count":122,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/50\/revisions"}],"predecessor-version":[{"id":4206,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/50\/revisions\/4206"}],"up":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/48"}],"wp:attachment":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/media?parent=50"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}